Clinical Trial Update: Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based Regimens [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial investigated the combination of capecitabine and interferon-Alpha in patients with metastatic renal cell carcinoma who failed IL-2–b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• Interferon-alpha (interferon alpha)

Snippet

Sponsor: Kidney Cancer Research Bureau | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: COMPLETED